Picture of Redwood Pharma AB logo

REDW — Redwood Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Redwood Pharma Receives Its Third And Last National Approval

Jan 7 (Reuters) - Redwood Pharma AB  REDWPH.TE :
    * REDWOOD PHARMA RECEIVES ITS THIRD AND LAST NATIONAL APPROVAL
    * OBTAINED ALL PLANNED NATIONAL APPROVALS IN AUSTRIA, HUNGARY AND GERMANY
    * GOT APPROVAL FROM GERMAN FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES (BFARM) TO
INITIATE
CLINICAL TRIAL OF RP101
    * CAN NOW PLAN AND START CLINICAL ACTIVITIES IN ALL COUNTRIES INVOLVED IN STUDY

Source text for Eikon:  ID:nWkr3hxsZg 
Further company coverage:  REDWPH.TE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Redwood Pharma AB

See all news